Cargando…

Evaluating the Oral-Health-Related Quality of Life of Oral Submucous Fibrosis Patients before and after Treatment Using the OHIP-14 Tool

The objective of the present study was to assess the oral-health-related quality of life (OHRQoL) of oral submucous fibrosis (OSMF) patients before and after standard treatment. A convenient sampling technique was used to recruit the clinically diagnosed patients of OSMF (n = 130). Based on the medi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Memon, Abdul Bari, Rahman, Aneela Atta Ur, Channar, Kashif Ali, Zafar, Muhammad Sohail, Kumar, Naresh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835519/ https://www.ncbi.nlm.nih.gov/pubmed/35162842 http://dx.doi.org/10.3390/ijerph19031821

Ejemplares similares

Assessing the Quality of Life of Oral Submucous Fibrosis Patients: A Cross-Sectional Study Using the WHOQOL-BREF Tool
por: Memon, Abdul Bari, et al.
Publicado: (2021)

Oral submucous fibrosis: an update
por: Wollina, Uwe, et al.
Publicado: (2015)

Oral submucous fibrosis: An update
por: Ray, Jay Gopal, et al.
Publicado: (2017)

Comparison of the OHIP-14 and GOHAI as measures of oral health among elderly in Lebanon
por: El Osta, Nada, et al.
Publicado: (2012)

Validation of a Persian Version of the Oral Health Impact Profile (OHIP-14)
por: Navabi, N, et al.
Publicado: (2010)

Use of Oral Health Impact Profile-14 (OHIP-14) in Different Contexts. What Is Being Measured?
por: Campos, Lucas Arrais, et al.
Publicado: (2021)

Lipid profile in oral submucous fibrosis
por: Mehrotra, Ravi, et al.
Publicado: (2009)

Medical management of oral submucous fibrosis
por: Shanbhag, Vagish Kumar Laxman
Publicado: (2015)

PTEN and α-SMA Expression and Diagnostic Role in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma with Concomitant Oral Submucous Fibrosis
por: Monteiro, Roshni, et al.
Publicado: (2021)

Dimensions of oral health related quality of life measured by EQ-5D+ and OHIP-14
por: Brennan, David S, et al.
Publicado: (2004)

Validation of the Spanish version of the Oral Health Impact Profile (OHIP-14Sp) in elderly Chileans
por: León, Soraya, et al.
Publicado: (2014)

Management of Oral Submucous Fibrosis with Injection of Hyaluronidase and Dexamethasone in Grade III Oral Submucous Fibrosis: A Retrospective Study
por: James, Leena, et al.
Publicado: (2015)

A Danish version of the oral health impact profile-14 (OHIP-14): translation and cross-cultural adaptation
por: Gera, Arwa, et al.
Publicado: (2020)

Dental Informatics tool “SOFPRO” for the study of oral submucous fibrosis
por: Erlewad, Dinesh Masajirao, et al.
Publicado: (2016)

Submucous fibrosis of the oral cavity. Histomorphological studies.
por: Wahi, P. N., et al.
Publicado: (1966)

Proliferation and apoptosis markers in oral submucous fibrosis
por: Ranganathan, K, et al.
Publicado: (2011)

Oral submucous fibrosis and its dermatological relation
por: Ali, Fareedi Mukram, et al.
Publicado: (2014)

Pathogenesis and therapeutic intervention of oral submucous fibrosis
por: Yoithapprabhunath, Thukanaykanpalayam Ragunathan, et al.
Publicado: (2013)

Immunohistochemical Analysis of Vimentin in Oral Submucous Fibrosis
por: Nayak, Meghanand T., et al.
Publicado: (2013)

Oral submucous fibrosis and plasma lipid profile
por: Pantvaidya, G. H., et al.
Publicado: (2013)

Oral submucous fibrosis: Are we doing enough?
por: Chugh, Ankita, et al.
Publicado: (2019)

Carcinoma Arising in the Background of Oral Submucous Fibrosis
por: Rangaswamy, Shruthi, et al.
Publicado: (2019)

Evaluation of Hematological Profile in Oral Submucous Fibrosis
por: Abidullah, Mohammed, et al.
Publicado: (2022)

Drug treatment for oral submucous fibrosis: an update
por: Chen, Xueru, et al.
Publicado: (2023)

Spanish version of the Oral Health Impact Profile (OHIP-Sp)
por: Lopez, Rodrigo, et al.
Publicado: (2006)

Comparison of Immunohistochemical Markers in Oral Submucous Fibrosis and Oral Submucous Fibrosis Transformed to Oral Squamous Cell Carcinoma—A Systematic Review and Meta-Analysis
por: Mohapatra, Diksha, et al.
Publicado: (2023)

Validation of a Greek version of the oral health impact profile (OHIP-14) for use among adults
por: Papagiannopoulou, Vassilia, et al.
Publicado: (2012)

Oral Health-Related Quality of Life in Chronic Liver Failure Patients Measured by OHIP-14 and GOHAI
por: Zahed, Maryam, et al.
Publicado: (2020)

Evaluation of Oral Pentoxifylline in the Management of Oral Submucous Fibrosis – An Ultrasonographic Study
por: Sadaksharam, Jayachandran, et al.
Publicado: (2017)

An overview of effect of lycopene and curcumin in oral leukoplakia and oral submucous fibrosis
por: Ahmad, Tanveer, et al.
Publicado: (2021)

PTMA, a new identified autoantigen for oral submucous fibrosis, regulates oral submucous fibroblast proliferation and extracellular matrix
por: Wang, Jie, et al.
Publicado: (2017)

Buccal fat pad reconstruction for oral submucous fibrosis
por: Surej, Kumar L. K., et al.
Publicado: (2010)

Ultrasonographic Evaluation of Oral Submucous Fibrosis and Masseteric Hypertrophy
por: Devathambi, Jones Raja, et al.
Publicado: (2013)

Prognostic potential of AgNORs in oral submucous fibrosis
por: Murgod, Sanjay, et al.
Publicado: (2016)

Areca nut and its role in oral submucous fibrosis
por: Prabhu, Rachana V., et al.
Publicado: (2014)

Plasma fibrinogen degradation products in oral submucous fibrosis
por: Gupta, Sonia, et al.
Publicado: (2015)

Evaluation of oxidative stress and the microenvironment in oral submucous fibrosis
por: Rai, Vertika, et al.
Publicado: (2019)

Effectiveness of Osteopathic Therapy in the Treatment of Oral Submucous Fibrosis
por: Goyal, Manu, et al.
Publicado: (2017)

Photobiomodulation therapy inhibits oral submucous fibrosis in mice
por: Chiang, Min‐Hsuan, et al.
Publicado: (2020)

Oral submucous fibrosis and COVID-19: Perspective on comorbidity
por: Sarode, Sachin C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rmlog1ufukr73i0ehc9v92ijfj